Montelukast deprescribing in outpatient specialty clinics: A single center cross-sectional study
Montelukast deprescribing rates were less than 5 % in outpatient specialty clinics. Factors associated with montelukast deprescribing beget further investigation.
Authors
- Stephen Neely
- Grant H. Skrepnek (ORCID: https://orcid.org/0000-0002-8563-8921)
- Jamie L. Miller (ORCID: https://orcid.org/0000-0002-6205-1095)
- Kiya Bennett
- Paul M. Boylan (ORCID: https://orcid.org/0000-0002-0719-8238)
- David C Foote
Institutions
- University of Oklahoma Health Sciences Center (US)
Publication Details
- Journal
- Exploratory Research in Clinical and Social Pharmacy
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1016/j.rcsop.2024.100509
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- University of Oklahoma
- Otsuka Pharmaceutical
- University of Oklahoma Health Sciences Center